All lobbying filings

AMERICAN KIDNEY FUND

Lobbying for AMERICAN KIDNEY FUND

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $240,000.00 expenses · posted Jul 20, 2026

Official filing document

Bills named in this filing 14

HR 6280
Access to Genetic Counselor Services Act of 2025
S 3607
Access to Genetic Counselor Services Act of 2026
HR 4582
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surge…
HR 4583
Living Donor Protection Act of 2025
S 1552
Living Donor Protection Act of 2025
HR 1518
New Era of Preventing End-Stage Kidney Disease Act
HR 2199
Restore Protections for Dialysis Patients Act
S 1173
Restore Protections for Dialysis Patients Act
HR 5259
Permanent OPTN Fee Authority Act
S 2751
Permanent OPTN Fee Authority Act
S 2730
Kidney Care Access Protection Act
HR 6214
Kidney Care Access Protection Act
HR 7868
Expanding Support for Living Donors Act of 2026
HR 8875
Improving Home Dialysis Act of 2026

Lobbying activity 1

Health Issues

Access to Genetic Counselor Services Act: H.R. 6280, S. 3607 Living Donor Protection Act: H.R. 4582, H.R 4583, S. 1552 Appropriations-NIH, NIDDK, Kidney Research The New Era for Preventing End-Stage Kidney Disease Act of 2025: H.R. 1518. Restore Protections for Dialysis Patients Act: H.R. 2199; S. 1173. Permanent OPTN Fee Authority Act: H.R.5259; S. 2751. Kidney Care Access Protection Act: S.2730. H.R. 6214 Expanding Support for Living Donors Act: H.R. 7868 Improving Home Dialysis Act: H.R. 8875 Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) Request for Information: Opportunities, Challenges, and Emerging Areas in Statistical Data, Analysis, and Research

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.